Joint with: Functional Neurocircuitry of Feeding and Feeding Disorders
Obesity and Adipose Tissue Biology
Feb 10–14, 2019 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Matthias Blüher, Philipp E. Scherer and Anne Bouloumié
In Person
Feb 10–14, 2019 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Matthias Blüher, Philipp E. Scherer and Anne Bouloumié
Available Formats:
Supported by the Directors' Fund
In Person
Important Deadlines
Early Registration Deadline:
December 11, 2018
Scholarship Deadline:
October 23, 2018
Global Health Award Deadline:
Deadlines not yet available for this meeting.
Short Talk Abstract Deadline:
Deadlines not yet available for this meeting.
Poster Abstract Deadline:
October 23, 2018
Meeting Summary
# Metabolism and Cardiovascular
Obesity is a growing worldwide epidemic, increasing co-morbid conditions, such as diabetes. The joint conferences on “Obesity and Adipose Tissue Biology” and “Functional Neurocircuitry of Feeding and Feeding Disorders” are aimed to foster cross-talk between these research areas. Adipose tissue is an endocrine organ that is both controlled by and sends signals to the brain and other organs. In addition, obesity causes an inflammatory state in the adipose tissue. The recognition that brown/beige adipose tissue is active in adult humans has triggered interest in understanding the physiology and relative importance of these tissues. Exercise and bariatric surgery are known to elicit profound metabolic benefits in type 2 diabetes, although the underlying mechanisms remain unclear. This conference will bring together cell biologists, biochemists, geneticists, physiologists, drug developers and clinical researchers, thereby facilitating knowledge exchange and interactions leading to elucidation of better treatments for obesity and diabetes. Specifically, it will examine recent advances in our understanding of brown/beige adipose tissue function; obesity-induced adipose inflammation; control of adipose tissue, appetite and energy metabolism; endocrine and paracrine signaling via secreted factors; molecular mechanisms of metabolic signaling; emerging topics, including long noncoding RNA and the gut microbiome; and approaches to drug development and the treatment of obesity and diabetes.
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS OUR MEETING EXHIBITOR(S):
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates